Accumulating evidence has linked PSMD14 to the pathogenesis of multiple human cancers—such as breast cancer, hepatocellular carcinoma, bladder cancer, glioblastoma, and osteosarcoma (13–19) —where it facilitates tumor progression primarily by stabilizing key oncogenic substrates through deubiquitination. Here, PSMD14 is linked to breast carcinoma.